journal article·2022-05-03Open access

Design, preparation, and functionalization of nanobiomaterials for enhanced efficacy in current and future biomedical applications

Poornima Ramburrun, Riaz A. Khan, Yahya E. Choonara

Nanotechnology Reviews· Volume 11· Issue 1

Abstract

Abstract Biocompatible, attuned, and congruent stimuli-responsive polymers of synthetic and plants and animals-based origins are essential raw materials for constructing bio-matching scaffolds, devices, and vehicles for payload deliveries, tissue engineering, therapeutics, and diagnostic purposes, and also as fill-in materials at biosites for various biomimetic applications. The nanobiomaterials for nanobiotechnology, nanopharmaceuticals, and nanobioengineering requires to have fit-in intrinsic chemical, physical, physico-chemical, mechanical, biological, and chemo-biological characteristics. The developed nanomaterials are also required to be receptive and biomimicking in quality, and they must not be toxic at any stage of use or implantation, minimally or of zero order degradation together with aging and use-related degradation, and last a life-time. The biomaterial at the upgraded scale needs to possess intricate characteristics equivalent to the biological materials, and compatible to the biological-sites during transportation, delivery, and site-unloading, and use. Recent developments in nanobiomaterial substrate designs and structure, characteristics, design requirements, chemo-biological interface related bio-systems response-compatibility, biomaterial synchronized, contemporaneous, and evolving applications in health care, therapeutics, nanomedicine, bio-hazard prevention, toxicity and ways of toxicity-control are outlined. The structure-function relationship, scope and limitations, structural and functional classes, and diversified biological outreach are discussed.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Graphene and Nanomaterials Applications · Nanoparticles: synthesis and applications · Bone Tissue Engineering Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Wits Advanced Drug Delivery Platform Research Unit, Department of Pharmacy and Pharmacology, School of Therapeutic Sciences, Faculty of Health Sciences, University of the Witwatersrand , Johannesburg , South Africa

Medicinal Chemistry and Pharmacognosy Department, College of Pharmacy, Qassim University , Qassim 51452 , Saudi Arabia

References (100+)

Show source-provided references
1. Hochella MF. There’s plenty of room at the bottom: nanoscience in geochemistry. Geochim Cosmochim Acta. 2002;66(5):735–43.10.1016/S0016-7037(01)00868-7 ↗
2. Hulbert SF. Ceramics in clinical applications: past, present and future. In: Vincenzini P, editor. High tech ceramics. Amsterdam: Elsevier; 1987. p. 189–213.
3. Thakur S, Agrawal R. Application of nanotechnology in pharmaceutical formulation design and development. Curr Drug Ther. 2015;10(1):20–34.10.2174/157488551001150825095729 ↗
4. Bayda S, Adeel M, Tuccinardi T, Cordani M, Rizzolio F. The history of nanoscience and nanotechnology: from chemical–physical applications to nanomedicine. Molecules. 2020;25(1):112.10.3390/molecules25010112 ↗
5. Singh N, Sharma UC. Introduction to nano-biomaterials. In: Navani NK, Sinha S, editors. Nanotechnology vol. 11 biomaterials. Texas: Studium Press LLC; 2014. p. 1–12.
6. Saleh TA. Nanomaterials: classification, properties, and environmental toxicities. Environ Technol Innov. 2020;20:101067.10.1016/j.eti.2020.101067 ↗
7. Salata OV. Applications of nanoparticles in biology and medicine. J Nanobiotechnol. 2004;2(1):3.10.1186/1477-3155-2-3 ↗
8. Ratner BD, Hoffman AS, Schoen FJ, Lemons JE. Biomaterials science: an introduction to materials in medicine. 2nd edn. Elsevier; 2004.
9. Balasundaram G, Webster TJ. Nanotechnology and biomaterials for orthopedic medical applications. Nanomedicine. 2006;1(2):169–76.10.2217/17435889.1.2.169 ↗
10. Saji VS, Choe HC, Yeung KWK. Nanotechnology in biomedical applications: a review. Int J Nano Biomater. 2010;3(2):119–39.10.1504/IJNBM.2010.037801 ↗
11. Schaeublin NM, Braydich-Stolle LK, Maurer EI, Park K, MacCuspie RI, Afrooz ARMN, et al. Does shape matter? Bioeffects of gold nanomaterials in a human skin cell model. Langmuir. 2012;28(6):3248–58.10.1021/la204081m ↗
12. Virlan MJR, Miricescu D, Radulescu R, Sabliov CM, Totan A, Calenic B, et al. Organic nanomaterials and their applications in the treatment of oral diseases. Molecules. 2016;21(2):207.10.3390/molecules21020207 ↗
13. Operti MC, Bernhardt A, Grimm S, Engel A, Figdor CG, Tagit O. PLGA-based nanomedicines manufacturing: technologies overview and challenges in industrial scale-up. Int J Pharm. 2021;605:120807.10.1016/j.ijpharm.2021.120807 ↗
14. Kumar P, Saini M, Dehiya BS, Sindhu A, Kumar V, Kumar R, et al. Comprehensive survey on nanobiomaterials for bone tissue engineering applications. Nanomaterials. 2020;10(10):2019.10.3390/nano10102019 ↗
15. Murali A, Lokhande G, Deo KA, Brokesh A, Gaharwar AK. Emerging 2D nanomaterials for biomedical applications. Mater Today. 2021;50:276–302.10.1016/j.mattod.2021.04.020 ↗
16. Massaro M, Cavallaro G, Colletti CG, Lazzara G, Milioto S, Noto R, et al. Chemical modification of halloysite nanotubes for controlled loading and release. J Mater Chem B. 2018;6(21):3415–33.10.1039/C8TB00543E ↗
17. Patel KD, Singh RK, Kim H-W. Carbon-based nanomaterials as an emerging platform for theranostics. Mater Horiz. 2019;6(3):434–69.10.1039/C8MH00966J ↗
18. Maiti D, Tong X, Mou X, Yang K. Carbon-based nanomaterials for biomedical applications: a recent study. Front Pharmacol. 2019;9:1401.10.3389/fphar.2018.01401 ↗
19. Sen M. Nanocomposite materials. In: Sen M, editor. Nanotechnology and the environment. London: IntechOpen; 2020. p. 107–12.10.5772/intechopen.93047 ↗
20. Turlybekuly A, Pogrebnjak AD, Sukhodub LF, Sukhodub LB, Kistaubayeva AS, Savitskaya IS, et al. Synthesis, characterization, in vitro biocompatibility and antibacterial properties study of nanocomposite materials based on hydroxyapatite-biphasic ZnO micro- and nanoparticles embedded in Alginate matrix. Mater Sci Eng C. 2019;104:109965.10.1016/j.msec.2019.109965 ↗
21. Liu Y, Yu Q, Chang J, Wu C. Nanobiomaterials: from 0D to 3D for tumor therapy and tissue regeneration. Nanoscale. 2019;11(29):13678–708.10.1039/C9NR02955A ↗
22. Torresan V, Forrer D, Guadagnini A, Badocco D, Pastore P, Casarin M, et al. 4D multimodal nanomedicines made of nonequilibrium Au–Fe alloy nanoparticles. ACS Nano. 2020;14(10):12840–53.10.1021/acsnano.0c03614 ↗
23. Liu M, Fakhrullin R, Novikov A, Panchal A, Lvov Y. Tubule nanoclay-organic heterostructures for biomedical applications. Macromol Biosci. 2019;19(4):1800419.10.1002/mabi.201800419 ↗
24. Yokota J, Kyotani S. Influence of nanoparticle size on the skin penetration, skin retention and anti-inflammatory activity of non-steroidal anti-inflammatory drugs. J Chin Med Assoc. 2018;81(6):511–9.10.1016/j.jcma.2018.01.008 ↗
25. Meng Q, Meng H, Pan Y, Liu J, Li J, Qi Y, et al. Influence of nanoparticle size on blood–brain barrier penetration and the accumulation of anti-seizure medicines in the brain. J Mater Chem B. 2022;10(2):271–81.10.1039/D1TB02015C ↗
26. Jahnen-Dechent W, Simon U. Function follows form: shape complementarity and nanoparticle toxicity. Nanomedicine. 2008;3(5):601–3.10.2217/17435889.3.5.601 ↗
27. Pan Y, Neuss S, Leifert A, Fischler M, Wen F, Simon U, et al. Size-dependent cytotoxicity of gold nanoparticles. Small. 2007;3(11):1941–9.10.1002/smll.200700378 ↗
28. Kim JS, Lee K, Lee YH, Cho HS, Kim KH, Choi KH, et al. Aspect ratio has no effect on genotoxicity of multi-wall carbon nanotubes. Arch Toxicol. 2011;85(7):775–86.10.1007/s00204-010-0574-0 ↗
29. Bauer LA, Birenbaum NS, Meyer GJ. Biological applications of high aspect ratio nanoparticles. J Mater Chem. 2004;14(4):517–26.10.1039/b312655b ↗
30. Fratila RM, Rivera-Fernández S, Jesús M. Shape matters: synthesis and biomedical applications of high aspect ratio magnetic nanomaterials. Nanoscale. 2015;7(18):8233–60.10.1039/C5NR01100K ↗
31. Luanpitpong S, Wang L, Davidson DC, Riedel H, Rojanasakul Y. Carcinogenic potential of high aspect ratio carbon nanomaterials. Environ Sci Nano. 2016;3(3):483–93.10.1039/C5EN00238A ↗
32. Yi X, Shi X, Gao H. A universal law for cell uptake of one-dimensional nanomaterials. Nano Lett. 2014;14(2):1049–55.10.1021/nl404727m ↗
33. Sanchez VC, Weston P, Yan A, Hurt RH, Kane AB. A 3-dimensional in vitro model of epithelioid granulomas induced by high aspect ratio nanomaterials. Part Fibre Toxicol. 2011;8(1):17.10.1186/1743-8977-8-17 ↗
34. Wan J, Wang J-H, Liu T, Xie Z, Yu X-F, Li W. Surface chemistry but not aspect ratio mediates the biological toxicity of gold nanorods in vitro and in vivo. Sci Rep. 2015;5(1):11398.10.1038/srep11398 ↗
35. Wang Y, Sun S, Zhang Z, Shi D. Nanomaterials for cancer precision medicine. Adv Mater. 2018;30(17):1705660.10.1002/adma.201705660 ↗
36. Auría-Soro C, Nesma T, Juanes-Velasco P, Landeira-Viñuela A, Fidalgo-Gomez H, Acebes-Fernandez V, et al. Interactions of nanoparticles and biosystems: microenvironment of nanoparticles and biomolecules in nanomedicine. Nanomaterials. 2019;9(10):1365.10.3390/nano9101365 ↗
37. Fröhlich E. Aufbau und funktion von blut-gewebe-schranken. Dtsch Med Wochenschr. 2002;127(49):2629–34. (German).10.1055/s-2002-35932 ↗
38. Bregoli L, Movia D, Gavigan-Imedio JD, Lysaght J, Reynolds J, Prina-Mello A. Nanomedicine applied to translational oncology: a future perspective on cancer treatment. Nanomed Nanotechnol Biol Med. 2016;12(1):81–103.10.1016/j.nano.2015.08.006 ↗
39. Ugwu MC, Amadi NC, Okolo CR, Dada MO, Egejuru CCJ, Ogbodo EC, et al. Nanomedicine: application of nanotechnology. European J Biomed Pharm Sci. 2017;4(12):136–43.
40. Melchor-Martínez EM, Torres Castillo NE, Macias-Garbett R, Lucero-Saucedo SL, Parra-Saldívar R, Sosa-Hernández JE. Modern world applications for nano-bio materials: tissue engineering and COVID-19. Front Bioeng Biotechnol. 2021;9:393.10.3389/fbioe.2021.597958 ↗
41. Khiev D, Mohamed ZA, Vichare R, Paulson R, Bhatia S, Mohapatra S, et al. Emerging nano-formulations and nanomedicines applications for ocular drug delivery. Nanomaterials. 2021;11(1):173.10.3390/nano11010173 ↗
42. Zhang W, Mehta A, Tong Z, Esser L, Voelcker NH. Development of polymeric nanoparticles for blood–brain barrier transfer – strategies and challenges. Adv Sci. 2021;8(10):2003937.10.1002/advs.202003937 ↗
43. Riggio C, Pagni E, Raffa V, Cuschieri A. Nano-oncology: clinical application for cancer therapy and future perspectives. J Nanomater. 2011;2011:17.10.1155/2011/164506 ↗
44. Zhang Y, Li M, Gao X, Chen Y, Liu T. Nanotechnology in cancer diagnosis: progress, challenges and opportunities. J Hematol Oncol. 2019;12(1):137.10.1186/s13045-019-0833-3 ↗
45. Anselmo AC, Mitragotri S. Nanoparticles in the clinic: an update. Bioeng Transl Med. 2019;4(3):e10143.10.1002/btm2.10143 ↗
46. Lôbo GCNB, Paiva KLR, Silva ALG, Simões MM, Radicchi MA, Báo SN. Nanocarriers used in drug delivery to enhance immune system in cancer therapy. Pharmaceutics. 2021;13(8):1167.10.3390/pharmaceutics13081167 ↗
47. Zhang Q, Yu H, Barbiero M, Wang B, Gu M. Artificial neural networks enabled by nanophotonics. Light: Sci Appl. 2019;8(1):42.10.1038/s41377-019-0151-0 ↗
48. Yang L, Zhang L, Webster TJ. Nanobiomaterials: state of the art and future trends. Adv Eng Mater. 2011;13(6):B197–B217.10.1002/adem.201080140 ↗
49. Shafiei-Irannejad V, Soleymani J, Azizi S, KhoubnasabJafari M, Jouyban A, Hasanzadeh M. Advanced nanomaterials towards biosensing of insulin: analytical approaches. TrAC - Trends Anal Chem. 2019;116:1–12.10.1016/j.trac.2019.04.020 ↗
50. Lei J, Ju H. Signal amplification using functional nanomaterials for biosensing. Chem Soc Rev. 2012;41(6):2122–34.10.1039/c1cs15274b ↗
51. Holzinger M, Le Goff A, Cosnier S. Synergetic effects of combined nanomaterials for biosensing applications. Sensors. 2017;17(5):1010.10.3390/s17051010 ↗
52. Hwang HS, Jeong JW, Kim YA, Chang M. Carbon nanomaterials as versatile platforms for biosensing applications. Micromachines. 2020;11(9):814.10.3390/mi11090814 ↗
53. Carneiro P, Morais S, Pereira MC. Nanomaterials towards biosensing of Alzheimer’s disease biomarkers. Nanomaterials. 2019;9(12):1663.10.3390/nano9121663 ↗
54. Mostafavi E, Medina-Cruz D, Kalantari K, Taymoori A, Soltantabar P, Webster TJ. Electroconductive nanobiomaterials for tissue engineering and regenerative medicine. Bioelectricity. 2020;2(2):120–49.10.1089/bioe.2020.0021 ↗
55. Di Marzio N, Eglin D, Serra T, Moroni L. Bio-fabrication: convergence of 3D bioprinting and nano-biomaterials in tissue engineering and regenerative medicine. Front Bioeng Biotechnol. 2020;8:326.10.3389/fbioe.2020.00326 ↗
56. Dvir T, Timko BP, Kohane DS, Langer R. Nanotechnological strategies for engineering complex tissues. Nat Nanotechnol. 2011;6(1):13–22.10.1038/nnano.2010.246 ↗
57. Hudita A, Galateanu B, Costache M. Chapter 1 – Nanobiomaterials for tissue engineering. In: Holban A-M, Grumezescu AM, editors. Materials for biomedical engineering. Amsterdam: Elsevier; 2019. p. 1–21.10.1016/B978-0-12-816909-4.00001-4 ↗
58. Nikolova MP, Chavali MS. Recent advances in biomaterials for 3D scaffolds: a review. Bioact Mater. 2019;4:271–92.10.1016/j.bioactmat.2019.10.005 ↗
59. Wang J, Vermerris W. Antimicrobial nanomaterials derived from natural products – a review. Materials. 2016;9(4):255.10.3390/ma9040255 ↗
60. Ogunsona EO, Muthuraj R, Ojogbo E, Valerio O, Mekonnen TH. Engineered nanomaterials for antimicrobial applications: a review. Appl Mater Today. 2020;18:100473.10.1016/j.apmt.2019.100473 ↗
61. Dickson MN, Liang EI, Rodriguez LA, Vollereaux N, Yee AF. Nanopatterned polymer surfaces with bactericidal properties. Biointerphases. 2015;10(2):021010.10.1116/1.4922157 ↗
62. Sánchez-López E, Gomes D, Esteruelas G, Bonilla L, Lopez-Machado AL, Galindo R, et al. Metal-based nanoparticles as antimicrobial agents: an overview. Nanomaterials. 2020;10(2):292.10.3390/nano10020292 ↗
63. Hasan A, Morshed M, Memic A, Hassan S, Webster TJ, Marei HE-S. Nanoparticles in tissue engineering: applications, challenges and prospects. Int J Nanomed. 2018;13:5637–55.10.2147/IJN.S153758 ↗
64. Hemeg HA. Nanomaterials for alternative antibacterial therapy. Int J Nanomed. 2017;12:8211–25.10.2147/IJN.S132163 ↗
65. Ramburrun P, Pringle NA, Dube A, Adam RZ, D’Souza S, Aucamp M. Recent advances in the development of antimicrobial and antifouling biocompatible materials for dental applications. Materials. 2021;14(12):3167.10.3390/ma14123167 ↗
66. Albanese A, Tang PS, Chan WCW. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012;14(1):1–16.10.1146/annurev-bioeng-071811-150124 ↗
67. Srivastava SK, Yadav VG. Bionic manufacturing: towards cyborg cells and sentient microbots. Trends Biotechnol. 2018;36(5):483–7.10.1016/j.tibtech.2017.11.002 ↗
68. Zahin N, Anwar R, Tewari D, Kabir MT, Sajid A, Mathew B, et al. Nanoparticles and its biomedical applications in health and diseases: special focus on drug delivery. Environ Sci Pollut Res. 2020;27(16):19151–68.10.1007/s11356-019-05211-0 ↗
69. Yadid M, Feiner R, Dvir T. Gold nanoparticle-integrated scaffolds for tissue engineering and regenerative medicine. Nano Lett. 2019;19(4):2198–206.10.1021/acs.nanolett.9b00472 ↗
70. Alam F, Yadav N, Ahmad M, Shadan M. Blood substitutes: possibilities with nanotechnology. Ind J Hematol Blood Transfus. 2014;30(3):155–62.10.1007/s12288-013-0309-5 ↗
71. Sheikhpour M, Arabi M, Kasaeian A, Rokn Rabei A, Taherian Z. Role of nanofluids in drug delivery and biomedical technology: methods and applications. Nanotechnol Sci Appl. 2020;13:47–59.10.2147/NSA.S260374 ↗
72. Fröhlich E. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. Int J Nanomed. 2012;7:5577–91.10.2147/IJN.S36111 ↗
73. Nienhaus K, Wang H, Nienhaus GU. Nanoparticles for biomedical applications: exploring and exploiting molecular interactions at the nano-bio interface. Mater Today Adv. 2020;5:100036.10.1016/j.mtadv.2019.100036 ↗
74. De-la-Pinta I, Cobos M, Ibarretxe J, Montoya E, Eraso E, Guraya T, et al. Effect of biomaterials hydrophobicity and roughness on biofilm development. J Mater Sci Mater Med. 2019;30(7):77.10.1007/s10856-019-6281-3 ↗
75. Saberi A, Jabbari F, Zarrintaj P, Saeb MR, Mozafari M. Electrically conductive materials: Opportunities and challenges in tissue engineering. Biomolecules. 2019;9(9):448.10.3390/biom9090448 ↗
76. Mnasri W, Parvizian M, Ammar-Merah S. Design and synthesis of luminescent lanthanide-based bimodal nanoprobes for dual magnetic resonance (MR) and optical imaging. Nanomaterials. 2021;11(2):354.10.3390/nano11020354 ↗
77. Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33(9):941–51.10.1038/nbt.3330 ↗
78. Saraiva C, Praça C, Ferreira R, Santos T, Ferreira L, Bernardino L. Nanoparticle-mediated brain drug delivery: overcoming blood–brain barrier to treat neurodegenerative diseases. J Control Release. 2016;235:34–47.10.1016/j.jconrel.2016.05.044 ↗
79. Truong NP, Whittaker MR, Mak CW, Davis TP. The importance of nanoparticle shape in cancer drug delivery. Expert Opin Drug Deliv. 2015;12(1):129–42.10.1517/17425247.2014.950564 ↗
80. Banerjee A, Qi J, Gogoi R, Wong J, Mitragotri S. Role of nanoparticle size, shape and surface chemistry in oral drug delivery. J Control Release. 2016;238:176–85.10.1016/j.jconrel.2016.07.051 ↗
81. Thau L, Asuka E, Mahajan K. Physiology, opsonization. StatPearls [Internet]. Treasure Island: StatPearls Publishing; 2021. p. 1–5.
82. van Rijt S, Habibovic P. Enhancing regenerative approaches with nanoparticles. J R Soc Interface. 2017;14(129):20170093.10.1098/rsif.2017.0093 ↗
83. Zhang L, Webster TJ. Nanotechnology and nanomaterials: promises for improved tissue regeneration. Nano Today. 2009;4(1):66–80.10.1016/j.nantod.2008.10.014 ↗
84. Lyu Q, Peng L, Hong X, Fan T, Li J, Cui Y, et al. Smart nano-micro platforms for ophthalmological applications: the state-of-the-art and future perspectives. Biomaterials. 2021;270:120682.10.1016/j.biomaterials.2021.120682 ↗
85. Gorantla S, Rapalli VK, Waghule T, Singh PP, Dubey SK, Saha RN, et al. Nanocarriers for ocular drug delivery: current status and translational opportunity. RSC Adv. 2020;10(46):27835–55.10.1039/D0RA04971A ↗
86. Mittal R, Pena SA, Zhu A, Eshraghi N, Fesharaki A, Horesh EJ, et al. Nanoparticle-based drug delivery in the inner ear: current challenges, limitations and opportunities. Artif Cells Nanomed Biotechnol. 2019;47(1):1312–20.10.1080/21691401.2019.1573182 ↗
87. Li L, Chao T, Brant J, O’Malley B, Tsourkas A, Li D. Advances in nano-based inner ear delivery systems for the treatment of sensorineural hearing loss. Adv Drug Deliv Rev. 2017;108:2–12.10.1016/j.addr.2016.01.004 ↗
88. Dindelegan MG, Blebea C, Perde-Schrepler M, Buzoianu AD, Maniu AA. Recent advances and future research directions for hearing loss treatment based on nanoparticles. J Nanomater. 2022;2022:7794384.10.1155/2022/7794384 ↗
89. Cai H, Wen X, Wen L, Tirelli N, Zhang X, Zhang Y, et al. Enhanced local bioavailability of single or compound drugs delivery to the inner ear through application of PLGA nanoparticles via round window administration. Int J Nanomed. 2014;9:5591–601.10.2147/IJN.S72555 ↗
90. Sun C, Wang X, Zheng Z, Chen D, Wang X, Shi F, et al. A single dose of dexamethasone encapsulated in polyethylene glycol-coated polylactic acid nanoparticles attenuates cisplatin-induced hearing loss following round window membrane administration. Int J Nanomed. 2015;10:3567–79.10.2147/IJN.S77912 ↗
91. Cervantes B, Arana L, Murillo-Cuesta S, Bruno M, Alkorta I, Varela-Nieto I. Solid lipid nanoparticles loaded with glucocorticoids protect auditory cells from cisplatin-induced ototoxicity. J Clin Med. 2019;8(9):1464.10.3390/jcm8091464 ↗
92. Gausterer JC, Saidov N, Ahmadi N, Zhu C, Wirth M, Reznicek G, et al. Intratympanic application of poloxamer 407 hydrogels results in sustained N-acetylcysteine delivery to the inner ear. Eur J Pharm Biopharm. 2020;150:143–55.10.1016/j.ejpb.2020.03.005 ↗
93. Lajud SA, Nagda DA, Qiao P, Tanaka N, Civantos A, Gu R, et al. A novel chitosan-hydrogel-based nanoparticle delivery system for local inner ear application. Otol Neurotol. 2015;36(2):341–7.10.1097/MAO.0000000000000445 ↗
94. Magdy M, Elmowafy E, Elassal M, Ishak RAH. Localized drug delivery to the middle ear: Recent advances and perspectives for the treatment of middle and inner ear diseases. J Drug Deliv Sci Technol. 2022;69:103149.10.1016/j.jddst.2022.103149 ↗
95. Rathnam C, Chueng S-TD, Ying Y-LM, Lee K-B, Kwan K. Developments in bio-inspired nanomaterials for therapeutic delivery to treat hearing loss. Front Cell Neurosci. 2019;13:493.10.3389/fncel.2019.00493 ↗
96. Berger M. Nanotechnology for neuroscience [Internet]. Nanowerk; 2017 [cited 2021 Dec 7]Available from: https://www.nanowerk.com/spotlight/spotid=48348.php
97. Shah S. The nanomaterial toolkit for neuroengineering. Nano Converg. 2016;3(1):25.10.1186/s40580-016-0086-6 ↗
98. Maheshwari V, Saraf R. Tactile devices to sense touch on a par with a human finger. Angew Chem - Int Ed. 2008;47(41):7808–26.10.1002/anie.200703693 ↗
99. Berger M. Nanotechnology skin to rival human touch [Internet]. Nanowerk; 2008 [cited 2021 Dec 7]Available from: https://www.nanowerk.com/spotlight/spotid=7497.php
100. Yu Z, Ying WB, Pravarthana D, Li YY, Mao GY, Liu YW, et al. Stretchable tactile sensor with high sensitivity and dynamic stability based on vertically aligned urchin-shaped nanoparticles. Mater Today Phys. 2020;14:100219.10.1016/j.mtphys.2020.100219 ↗